HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVD

Information

• Research Project
• 8930878

• ApplicationId

  8930878

• Core Project Number

  N01AI000000

• Full Project Number

  N01AI60019-11-0-1

• Serial Number

• FOA Number

• Sub Project Id

• Project Start Date

  9/30/2006 - 18 years ago

• Project End Date

  7/31/2016 - 8 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2014

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• Argos Therapeutics, Inc.

The goal of this Research Program is to design, develop, and clinically test an autologous HIV immunotherapy capable of eliciting therapeutic immune responses and which is comprised of autologous monocyte-derived dendritic cells modified to express selected autologous HIV proteins representing a multiplicity of patient-specific quasispecies

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  505050

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:505050\

• Funding Mechanism

  Non SBIR/STTR Contracts

• Study Section

• Study Section Name

• Organization Name

  ARGOS THERAPEUTICS, INC.

• Organization Department

• Organization DUNS

  155355030

• Organization City

  DURHAM

• Organization State

  NC

• Organization Country

  UNITED STATES

• Organization Zip Code

  277042173

• Organization District

  UNITED STATES